Mechanisms of phorbol ester-induced endothelial cells (EC) barrier dysfunction

Alexander Dmitriyevich Verin, Stephen D. Durbin, Lucy Robles Rivera, Doug J. Lowery, Jerome Stasek, Carolyn E. Patterson, Joe G.N. Garcia

Research output: Contribution to journalArticle

Abstract

Receptor-mediated agonists such as thrombin increase EC permeability via a sequence involving myosin light chain kinase (MLCK) activation, myosin light chain (MLC) phosphorylation, actin-myosin complex formation, contraction and intercellular gap formation. Although phorbol myristate acetate (PMA), a direct protein kinase C (PKC) activator, also induces gap formation and compromises barrier integrity, our recent evidence utilizing urea gel electrophoresis suggested that PMA-induced EC barrier dysfunction does not involve MLCK-mediated MLC phosphorylation. To investigate mechanisms regulating PMA-induced EC barrier dysfunction, we studied the effect of PMA on the distribution of key EC contractile proteins in the detergent (1% NP-40)-soluble (cytoplasmic) and -insoluble (cytoskeletal) fractions. PMA (100 nM) caused a time-dependent shift in the redistribution of actin, caldesmon (CaD, acalmodulin-, actin-, and myosin-binding protein), myosin heavy chains (HMM), MLC, but not MLCK from the cytoplasmic to the cytoskeletal fractions as demonstrated by immunoblotting. This redistribution coincided wiüi PMA-induced increase in CaD phosphorylation (immunoprecipitation with specific antiCaD antibodies) in 32P-labeled EC monolayers. Fractionation of 32P-labeled EC followed by immunoblotting with specific antibodies showed that PMA-stimulated CaD phosphorylation occured predominantly in the detergent-insoluble fraction. Western immunoblotting of EC proteins with specific anti-MLC antibodies showed that SDS homogenates included 2 unmunoreactive MLC proteins with an apparent difference in molecular weights of ∼ 1 kD, an MLCA (MLC21) and MLCB (MLC10). In contrast, the detergent-soluble fraction included only MLCA and the detergent-insoluble fraction was enriched in MLCB. Immunoprecipitation of MLC under non-denaturing conditions or urea buffer treatment of EC TCA precipitates leads to extraction only MLCA, but not MLCB. Thrombin, but not PMA, altered MLCA phosphorylation in this fraction, whereas MLC immunoprecipitation under denaturing conditions (in the presense of SDS) from 32P-labeled EC leads to significant MLCB phosphorylation in both PMA- and thrombin-stimulated EC. These data indicate that EC activation by PMA may increase EC permeability by inducing contractile protein reorganization which unlike thrombin, does not require MLCA phosphorylation, but may depend upon CaD and MLCB phosphorylation.

Original languageEnglish (US)
JournalJournal of Investigative Medicine
Volume44
Issue number3
StatePublished - Jan 1 1996
Externally publishedYes

Fingerprint

Endothelial cells
Phorbol Esters
Tetradecanoylphorbol Acetate
Phosphorylation
Endothelial Cells
Myosin Light Chains
Myosin-Light-Chain Kinase
Thrombin
Detergents
Immunoprecipitation
Actins
Contractile Proteins
Myosins
Immunoblotting
Urea
Antibodies
Permeability
Chemical activation
Calmodulin-Binding Proteins
Microfilament Proteins

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Verin, A. D., Durbin, S. D., Rivera, L. R., Lowery, D. J., Stasek, J., Patterson, C. E., & Garcia, J. G. N. (1996). Mechanisms of phorbol ester-induced endothelial cells (EC) barrier dysfunction. Journal of Investigative Medicine, 44(3).

Mechanisms of phorbol ester-induced endothelial cells (EC) barrier dysfunction. / Verin, Alexander Dmitriyevich; Durbin, Stephen D.; Rivera, Lucy Robles; Lowery, Doug J.; Stasek, Jerome; Patterson, Carolyn E.; Garcia, Joe G.N.

In: Journal of Investigative Medicine, Vol. 44, No. 3, 01.01.1996.

Research output: Contribution to journalArticle

Verin, AD, Durbin, SD, Rivera, LR, Lowery, DJ, Stasek, J, Patterson, CE & Garcia, JGN 1996, 'Mechanisms of phorbol ester-induced endothelial cells (EC) barrier dysfunction', Journal of Investigative Medicine, vol. 44, no. 3.
Verin AD, Durbin SD, Rivera LR, Lowery DJ, Stasek J, Patterson CE et al. Mechanisms of phorbol ester-induced endothelial cells (EC) barrier dysfunction. Journal of Investigative Medicine. 1996 Jan 1;44(3).
Verin, Alexander Dmitriyevich ; Durbin, Stephen D. ; Rivera, Lucy Robles ; Lowery, Doug J. ; Stasek, Jerome ; Patterson, Carolyn E. ; Garcia, Joe G.N. / Mechanisms of phorbol ester-induced endothelial cells (EC) barrier dysfunction. In: Journal of Investigative Medicine. 1996 ; Vol. 44, No. 3.
@article{e0e893b40e4a4d379d607b3f97aa4396,
title = "Mechanisms of phorbol ester-induced endothelial cells (EC) barrier dysfunction",
abstract = "Receptor-mediated agonists such as thrombin increase EC permeability via a sequence involving myosin light chain kinase (MLCK) activation, myosin light chain (MLC) phosphorylation, actin-myosin complex formation, contraction and intercellular gap formation. Although phorbol myristate acetate (PMA), a direct protein kinase C (PKC) activator, also induces gap formation and compromises barrier integrity, our recent evidence utilizing urea gel electrophoresis suggested that PMA-induced EC barrier dysfunction does not involve MLCK-mediated MLC phosphorylation. To investigate mechanisms regulating PMA-induced EC barrier dysfunction, we studied the effect of PMA on the distribution of key EC contractile proteins in the detergent (1{\%} NP-40)-soluble (cytoplasmic) and -insoluble (cytoskeletal) fractions. PMA (100 nM) caused a time-dependent shift in the redistribution of actin, caldesmon (CaD, acalmodulin-, actin-, and myosin-binding protein), myosin heavy chains (HMM), MLC, but not MLCK from the cytoplasmic to the cytoskeletal fractions as demonstrated by immunoblotting. This redistribution coincided wi{\"u}i PMA-induced increase in CaD phosphorylation (immunoprecipitation with specific antiCaD antibodies) in 32P-labeled EC monolayers. Fractionation of 32P-labeled EC followed by immunoblotting with specific antibodies showed that PMA-stimulated CaD phosphorylation occured predominantly in the detergent-insoluble fraction. Western immunoblotting of EC proteins with specific anti-MLC antibodies showed that SDS homogenates included 2 unmunoreactive MLC proteins with an apparent difference in molecular weights of ∼ 1 kD, an MLCA (MLC21) and MLCB (MLC10). In contrast, the detergent-soluble fraction included only MLCA and the detergent-insoluble fraction was enriched in MLCB. Immunoprecipitation of MLC under non-denaturing conditions or urea buffer treatment of EC TCA precipitates leads to extraction only MLCA, but not MLCB. Thrombin, but not PMA, altered MLCA phosphorylation in this fraction, whereas MLC immunoprecipitation under denaturing conditions (in the presense of SDS) from 32P-labeled EC leads to significant MLCB phosphorylation in both PMA- and thrombin-stimulated EC. These data indicate that EC activation by PMA may increase EC permeability by inducing contractile protein reorganization which unlike thrombin, does not require MLCA phosphorylation, but may depend upon CaD and MLCB phosphorylation.",
author = "Verin, {Alexander Dmitriyevich} and Durbin, {Stephen D.} and Rivera, {Lucy Robles} and Lowery, {Doug J.} and Jerome Stasek and Patterson, {Carolyn E.} and Garcia, {Joe G.N.}",
year = "1996",
month = "1",
day = "1",
language = "English (US)",
volume = "44",
journal = "Journal of Investigative Medicine",
issn = "1081-5589",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Mechanisms of phorbol ester-induced endothelial cells (EC) barrier dysfunction

AU - Verin, Alexander Dmitriyevich

AU - Durbin, Stephen D.

AU - Rivera, Lucy Robles

AU - Lowery, Doug J.

AU - Stasek, Jerome

AU - Patterson, Carolyn E.

AU - Garcia, Joe G.N.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Receptor-mediated agonists such as thrombin increase EC permeability via a sequence involving myosin light chain kinase (MLCK) activation, myosin light chain (MLC) phosphorylation, actin-myosin complex formation, contraction and intercellular gap formation. Although phorbol myristate acetate (PMA), a direct protein kinase C (PKC) activator, also induces gap formation and compromises barrier integrity, our recent evidence utilizing urea gel electrophoresis suggested that PMA-induced EC barrier dysfunction does not involve MLCK-mediated MLC phosphorylation. To investigate mechanisms regulating PMA-induced EC barrier dysfunction, we studied the effect of PMA on the distribution of key EC contractile proteins in the detergent (1% NP-40)-soluble (cytoplasmic) and -insoluble (cytoskeletal) fractions. PMA (100 nM) caused a time-dependent shift in the redistribution of actin, caldesmon (CaD, acalmodulin-, actin-, and myosin-binding protein), myosin heavy chains (HMM), MLC, but not MLCK from the cytoplasmic to the cytoskeletal fractions as demonstrated by immunoblotting. This redistribution coincided wiüi PMA-induced increase in CaD phosphorylation (immunoprecipitation with specific antiCaD antibodies) in 32P-labeled EC monolayers. Fractionation of 32P-labeled EC followed by immunoblotting with specific antibodies showed that PMA-stimulated CaD phosphorylation occured predominantly in the detergent-insoluble fraction. Western immunoblotting of EC proteins with specific anti-MLC antibodies showed that SDS homogenates included 2 unmunoreactive MLC proteins with an apparent difference in molecular weights of ∼ 1 kD, an MLCA (MLC21) and MLCB (MLC10). In contrast, the detergent-soluble fraction included only MLCA and the detergent-insoluble fraction was enriched in MLCB. Immunoprecipitation of MLC under non-denaturing conditions or urea buffer treatment of EC TCA precipitates leads to extraction only MLCA, but not MLCB. Thrombin, but not PMA, altered MLCA phosphorylation in this fraction, whereas MLC immunoprecipitation under denaturing conditions (in the presense of SDS) from 32P-labeled EC leads to significant MLCB phosphorylation in both PMA- and thrombin-stimulated EC. These data indicate that EC activation by PMA may increase EC permeability by inducing contractile protein reorganization which unlike thrombin, does not require MLCA phosphorylation, but may depend upon CaD and MLCB phosphorylation.

AB - Receptor-mediated agonists such as thrombin increase EC permeability via a sequence involving myosin light chain kinase (MLCK) activation, myosin light chain (MLC) phosphorylation, actin-myosin complex formation, contraction and intercellular gap formation. Although phorbol myristate acetate (PMA), a direct protein kinase C (PKC) activator, also induces gap formation and compromises barrier integrity, our recent evidence utilizing urea gel electrophoresis suggested that PMA-induced EC barrier dysfunction does not involve MLCK-mediated MLC phosphorylation. To investigate mechanisms regulating PMA-induced EC barrier dysfunction, we studied the effect of PMA on the distribution of key EC contractile proteins in the detergent (1% NP-40)-soluble (cytoplasmic) and -insoluble (cytoskeletal) fractions. PMA (100 nM) caused a time-dependent shift in the redistribution of actin, caldesmon (CaD, acalmodulin-, actin-, and myosin-binding protein), myosin heavy chains (HMM), MLC, but not MLCK from the cytoplasmic to the cytoskeletal fractions as demonstrated by immunoblotting. This redistribution coincided wiüi PMA-induced increase in CaD phosphorylation (immunoprecipitation with specific antiCaD antibodies) in 32P-labeled EC monolayers. Fractionation of 32P-labeled EC followed by immunoblotting with specific antibodies showed that PMA-stimulated CaD phosphorylation occured predominantly in the detergent-insoluble fraction. Western immunoblotting of EC proteins with specific anti-MLC antibodies showed that SDS homogenates included 2 unmunoreactive MLC proteins with an apparent difference in molecular weights of ∼ 1 kD, an MLCA (MLC21) and MLCB (MLC10). In contrast, the detergent-soluble fraction included only MLCA and the detergent-insoluble fraction was enriched in MLCB. Immunoprecipitation of MLC under non-denaturing conditions or urea buffer treatment of EC TCA precipitates leads to extraction only MLCA, but not MLCB. Thrombin, but not PMA, altered MLCA phosphorylation in this fraction, whereas MLC immunoprecipitation under denaturing conditions (in the presense of SDS) from 32P-labeled EC leads to significant MLCB phosphorylation in both PMA- and thrombin-stimulated EC. These data indicate that EC activation by PMA may increase EC permeability by inducing contractile protein reorganization which unlike thrombin, does not require MLCA phosphorylation, but may depend upon CaD and MLCB phosphorylation.

UR - http://www.scopus.com/inward/record.url?scp=33749449781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749449781&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33749449781

VL - 44

JO - Journal of Investigative Medicine

JF - Journal of Investigative Medicine

SN - 1081-5589

IS - 3

ER -